1. Home
  2. WFCF vs SER Comparison

WFCF vs SER Comparison

Compare WFCF & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WFCF

Where Food Comes From Inc.

HOLD

Current Price

$13.13

Market Cap

59.1M

Sector

Technology

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$3.34

Market Cap

42.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WFCF
SER
Founded
1996
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.1M
42.0M
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
WFCF
SER
Price
$13.13
$3.34
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
3.8K
15.3K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
45.82
N/A
EPS
0.53
N/A
Revenue
$25,512,000.00
$116,000.00
Revenue This Year
N/A
$134.46
Revenue Next Year
N/A
N/A
P/E Ratio
$24.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.26
$3.15
52 Week High
$13.78
$7.92

Technical Indicators

Market Signals
Indicator
WFCF
SER
Relative Strength Index (RSI) 58.31 31.13
Support Level $12.50 $3.15
Resistance Level $13.43 $4.26
Average True Range (ATR) 0.45 0.25
MACD 0.10 -0.03
Stochastic Oscillator 86.24 4.50

Price Performance

Historical Comparison
WFCF
SER

About WFCF Where Food Comes From Inc.

Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: